Compare Injective (INJ) vs Unibase (UB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Injective vs Unibase — how do they compare? Injective trades at Rp92,698 (market cap Rp9,26T, Rp1,75T 24h volume), while Unibase trades at Rp1,380 (market cap Rp3,41T, Rp5,8T 24h volume). The key difference: Injective is far larger — about 2.7× Unibase's market cap, and Unibase's supply is capped (2,5B / 10B UB (25%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Unibase for 2 Days on average.
| INJ | UB | |
|---|---|---|
Market Cap | Rp9,26T | Rp3,41T |
Volume (24h) | Rp1,75T | Rp5,8T |
Circulating Supply | 100M INJ | 2,5B / 10B UB (25%) |
Typical Hold Time | 36 Days | 2 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
Unibase (UB) is trading at Rp1,515 with a market cap of Rp3.82 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token has a circulating supply of 2.5 million out of 10 million max, with a 25% circulation rate. Key support lies at Rp1,132, while resistance is at Rp1,591. No major protocol updates or ecosystem news are available.
Overall outlook remains cautious due to bearish technicals and limited fundamental catalysts. Opportunities exist if support holds, but risks include low liquidity and high volatility. Investors should monitor for any network developments or exchange listings that could impact sentiment.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →About Unibase
Unibase is a decentralized AI infrastructure protocol that provides autonomous agents with persistent memory, interoperability, and self-evolution capabilities. It addresses agent statelessness and data silos by providing a decentralized memory layer that combines verifiable storage, cross-agent communication, and high-speed data availability. UB is used for protocol fees, governance, staking, and knowledge-based rewards.
Read more on UB →
